Pharmaceutical Biology · 2008 · 35 citations · 19 references
MedicineOncologyPharmacologyBiochemical PharmacologyCancer PharmacologyStructure-activity RelationshipsMedicinal Plant KnowledgeMedicinal PlantsOncology PharmacologyAnticancer ActivityAnticancer Compound ScreeningAnticancer Natural ProductsBioactive Plant CompoundsExtractMedicinal Plant ResourcesOvarian Cancer FractionationPharmacological Screening
Salvia hypargeia. Fisch. et Mey. (Lamiaceae) root extract, among 16 Salvia. extracts, showed the highest activity against the human ovarian cancer cell line. Bioactivity-guided fractionation of this plant extract has yielded four abietane-type diterpenes [5,6-didehydro-7-hydroxytaxodone (1), 14-deoxycoleon U (= 6-hydroxysalvinolone) (2), demethylcryptojaponol (3), and salvicanaric acid (4)] two triterpenes (lupeol and lupeol-3-acetate), and a fatty acid mixture consisting mainly of palmitic acid (51.6%) and palmitoleic acid (6.4%). Compounds 2 and 3 were found to be active against A2780 human ovarian cancer cell line with IC50 values of 3.9 and 1.2 μ g/mL, respectively, and the fatty acid composition was the most active part of the extract (IC50 = 0.6 μ g/mL).
19